Summary of Study ST003363
This data is available at the NIH Common Fund's National Metabolomics Data Repository (NMDR) website, the Metabolomics Workbench, https://www.metabolomicsworkbench.org, where it has been assigned Project ID PR002089. The data can be accessed directly via it's Project DOI: 10.21228/M8KR7D This work is supported by NIH grant, U2C- DK119886.
See: https://www.metabolomicsworkbench.org/about/howtocite.php
This study contains a large results data set and is not available in the mwTab file. It is only available for download via FTP as data file(s) here.
Study ID | ST003363 |
Study Title | Human milk microbiome across lactation stages and free glutamate concentrations in healthy Ecuadorian women |
Study Summary | Project Summary: To examine the differences in microbiome and glutamate concentrations in human breast milk among different lactation stages (colostrum-, transition-, and mature-milk), a longitudinal cohort study for healthy Ecuadorian women was conducted. This deposition is for the glutamate analysis. |
Institute | Universidad Internacional del Ecuador |
Laboratory | Collaboration with the Edison Lab at UGA |
Last Name | Uchimiya |
First Name | Mario |
Address | 315 Riverbend Rd, Athens, GA, 30602, USA |
mario.uchimiya@uga.edu | |
Phone | (706) 542-8387 |
Submit Date | 2024-07-29 |
Raw Data Available | Yes |
Raw Data File Type(s) | ser |
Analysis Type Detail | NMR |
Release Date | 2024-08-29 |
Release Version | 1 |
Select appropriate tab below to view additional metadata details:
Project:
Project ID: | PR002089 |
Project DOI: | doi: 10.21228/M8KR7D |
Project Title: | Human milk microbiome across lactation stages and free glutamate concentrations in healthy Ecuadorian women |
Project Summary: | Project Summary: To examine the differences in microbiome and glutamate concentrations in human breast milk among different lactation stages (colostrum-, transition-, and mature-milk), a longitudinal cohort study for healthy Ecuadorian women was conducted. This deposition is for the glutamate analysis. |
Institute: | University of Georgia |
Last Name: | Uchimiya |
First Name: | Mario |
Address: | 315 Riverbend Rd, Athens, GA, 30602, USA |
Email: | mario.uchimiya@uga.edu |
Phone: | (706) 542-8387 |
Funding Source: | International Glutamate Technical Committee (MEB); Universidad Internacional del Ecuador (MEB) |
Project Comments: | This is a deposition for a study led by Manuel E. Baldeon and Lizbeth Peña at the Universidad Internacional del Ecuador (MEB) |
Contributors: | Manuel E. Baldeon; Lizbeth Peña |
Subject:
Subject ID: | SU003484 |
Subject Type: | Human |
Subject Species: | Homo sapiens |
Taxonomy ID: | 9606 |
Factors:
Subject type: Human; Subject species: Homo sapiens (Factor headings shown in green)
mb_sample_id | local_sample_id | Sample source | Lactation_stage | gender |
---|---|---|---|---|
SA365941 | 61-Pool1 | Human breast milk | 0 | 0 |
SA365942 | 68-External_Control1 | Human breast milk | 0 | 0 |
SA365943 | 64-Pool4 | Human breast milk | 0 | 0 |
SA365944 | 70-External_Control3 | Human breast milk | 0 | 0 |
SA365945 | 63-Pool3 | Human breast milk | 0 | 0 |
SA365946 | 65-Pool5 | Human breast milk | 0 | 0 |
SA365947 | 62-Pool2 | Human breast milk | 0 | 0 |
SA365948 | 69-External_Control2 | Human breast milk | 0 | 0 |
SA365949 | 19-BBA_69e_C | Human breast milk | 1 | 1 |
SA365950 | 3-BBA_17e_C | Human breast milk | 1 | 1 |
SA365951 | 1-BBA_10e_C | Human breast milk | 1 | 1 |
SA365952 | 14-BBA_48e_C | Human breast milk | 1 | 1 |
SA365953 | 20-BBA_70e_C | Human breast milk | 1 | 1 |
SA365954 | 5-BBA_19e_C | Human breast milk | 1 | 1 |
SA365955 | 18-BBA_67e_C | Human breast milk | 1 | 1 |
SA365956 | 13-BBA_47e_C | Human breast milk | 1 | 1 |
SA365957 | 7-BBA_24e_C | Human breast milk | 1 | 1 |
SA365958 | 16-BBA_60e_C | Human breast milk | 1 | 1 |
SA365959 | 10-BBA_43e_C | Human breast milk | 1 | 2 |
SA365960 | 8-BBA_39e_C | Human breast milk | 1 | 2 |
SA365961 | 12-BBA_45e_C | Human breast milk | 1 | 2 |
SA365962 | 9-BBA_40e_C | Human breast milk | 1 | 2 |
SA365963 | 11-BBA_44e_C | Human breast milk | 1 | 2 |
SA365964 | 6-BBA_22e_C | Human breast milk | 1 | 2 |
SA365965 | 15-BBA_55e_C | Human breast milk | 1 | 2 |
SA365966 | 4-BBA_18e_C | Human breast milk | 1 | 2 |
SA365967 | 2-BBA_16e_C | Human breast milk | 1 | 2 |
SA365968 | 17-BBA_61e_C | Human breast milk | 1 | 2 |
SA365969 | 39-BBA_69e_T | Human breast milk | 2 | 1 |
SA365970 | 34-BBA_48e_T | Human breast milk | 2 | 1 |
SA365971 | 25-BBA_19e_T | Human breast milk | 2 | 1 |
SA365972 | 38-BBA_67e_T | Human breast milk | 2 | 1 |
SA365973 | 33-BBA_47e_T | Human breast milk | 2 | 1 |
SA365974 | 27-BBA_24e_T | Human breast milk | 2 | 1 |
SA365975 | 23-BBA_17e_T | Human breast milk | 2 | 1 |
SA365976 | 36-BBA_60e_T | Human breast milk | 2 | 1 |
SA365977 | 40-BBA_70e_T | Human breast milk | 2 | 1 |
SA365978 | 21-BBA_10e_T | Human breast milk | 2 | 1 |
SA365979 | 32-BBA_45e_T | Human breast milk | 2 | 2 |
SA365980 | 37-BBA_61e_T | Human breast milk | 2 | 2 |
SA365981 | 26-BBA_22e_T | Human breast milk | 2 | 2 |
SA365982 | 31-BBA_44e_T | Human breast milk | 2 | 2 |
SA365983 | 22-BBA_16e_T | Human breast milk | 2 | 2 |
SA365984 | 35-BBA_55e_T | Human breast milk | 2 | 2 |
SA365985 | 30-BBA_43e_T | Human breast milk | 2 | 2 |
SA365986 | 28-BBA_39e_T | Human breast milk | 2 | 2 |
SA365987 | 29-BBA_40e_T | Human breast milk | 2 | 2 |
SA365988 | 24-BBA_18e_T | Human breast milk | 2 | 2 |
SA365989 | 60-BBA_70e_M | Human breast milk | 3 | 1 |
SA365990 | 58-BBA_67e_M | Human breast milk | 3 | 1 |
SA365991 | 47-BBA_24e_M | Human breast milk | 3 | 1 |
SA365992 | 41-BBA_10e_M | Human breast milk | 3 | 1 |
SA365993 | 59-BBA_69e_M | Human breast milk | 3 | 1 |
SA365994 | 53-BBA_47e_M | Human breast milk | 3 | 1 |
SA365995 | 43-BBA_17e_M | Human breast milk | 3 | 1 |
SA365996 | 56-BBA_60e_M | Human breast milk | 3 | 1 |
SA365997 | 45-BBA_19e_M | Human breast milk | 3 | 1 |
SA365998 | 54-BBA_48e_M | Human breast milk | 3 | 1 |
SA365999 | 57-BBA_61e_M | Human breast milk | 3 | 2 |
SA366000 | 48-BBA_39e_M | Human breast milk | 3 | 2 |
SA366001 | 50-BBA_43e_M | Human breast milk | 3 | 2 |
SA366002 | 44-BBA_18e_M | Human breast milk | 3 | 2 |
SA366003 | 51-BBA_44e_M | Human breast milk | 3 | 2 |
SA366004 | 49-BBA_40e_M | Human breast milk | 3 | 2 |
SA366005 | 46-BBA_22e_M | Human breast milk | 3 | 2 |
SA366006 | 42-BBA_16e_M | Human breast milk | 3 | 2 |
SA366007 | 55-BBA_55e_M | Human breast milk | 3 | 2 |
SA366008 | 52-BBA_45e_M | Human breast milk | 3 | 2 |
SA366009 | 66-Extr_Blank1 | n.a. | 0 | 0 |
SA366010 | 67-Extr_Blank2 | n.a. | 0 | 0 |
SA366011 | Buffer phosphate blank | n.a. | 0 | 0 |
Showing results 1 to 71 of 71 |
Collection:
Collection ID: | CO003477 |
Collection Summary: | 7.5 to 20 mL of milk samples were collected from mothers and kept in sterile 50-mL tubes (Sigma-Aldrich). The samples were kept cold and transported to the laboratory within the first two hours of the sampling. 5 mL of the breast milk samples were aliquoted in cryovials and stored at -80oC for glutamate analysis. Lactation stage 1 = colostrum, 2 = transition, 3 = mature. |
Sample Type: | Milk |
Treatment:
Treatment ID: | TR003493 |
Treatment Summary: | Mothers were recruited at Hospital Gineco Obstétrico Isidro Ayora in Quito, Ecuador. The participating mothers were permanent residents and indicated their willingness to exclusively breastfeed for at least two months. Mothers were healthy, ≥18 years of age, and primiparous, and they had not consumed antibiotics or probiotics during pregnancy. Each mother had given birth to a full-term baby via vaginal delivery. A total of 20 mothers donated their colostrum- (human milk from 1-7 days postpartum), transition- (15 days postpartum), and mature-milk (30 days postpartum). For Factor_2 (gender) in Study Design, 1: participant with a female baby; 2: one with a male baby; 0: not applicable. |
Sample Preparation:
Sampleprep ID: | SP003491 |
Sampleprep Summary: | Human breast milk samples were extracted using a two-phase extraction method. 2 mL of chloroform-methanol (2:1) was added to each breast milk sample and vortexed for 10 seconds. 600 µL of water was then added to each sample and the mixture was centrifuged. 800 µL of the polar phase from each sample was transferred into a 1.5mL glass tube. The samples were then dried using a speed vacuum centrifuge. The polar phase was reconstituted in 700 µL of a phosphate buffer (pH 7.4; 1M TSP). The samples were transferred to 5-mm NMR tubes for NMR analysis. |
Sampleprep Protocol Filename: | 4_Sample_preparation_protocol_Glu_2024.pdf |
Processing Storage Conditions: | 4℃ |
Analysis:
Analysis ID: | AN005509 |
Analysis Type: | NMR |
Analysis Protocol File: | 5_Analysis_protocol_Glu_2024.pdf |
Num Factors: | 8 |
Num Metabolites: | 1 |
Units: | NMR peak intensity |
NMR:
NMR ID: | NM000288 |
Analysis ID: | AN005509 |
Instrument Name: | Bruker AVANCE lll |
Instrument Type: | FT-NMR |
NMR Experiment Type: | 2D-1H-1H |
NMR Comments: | The raw NMR data files are in the 'Spectra' folder. |
Spectrometer Frequency: | 600 |